Profilaxia da úlcera de estresse no ambiente de terapia intensiva em uma unidade hospitalar no município de Anápolis-Go

Authors

  • Thiago Hayashida Teles de Carvalho Hospital das Forças Armadas

DOI:

https://doi.org/10.37951/2358-9868.2021v9i2.p63-70

Keywords:

Úlcera péptica; fatores de risco; prevenção.

Abstract

Objective: Evaluate the stress ulcer prophylaxis (SUP) in patients hospitalized in an intensive care unit (ICU) of and private hospital unit, midsized and of high complexity in Anapolis - Goias. Methods: is an retrospective and descriptive study of medical records of over 18 years old patients in the ICU, in the period of January to June, 2017. Was obtained data about sociodemographic profile (including sex and age), risk profile of developing stress ulcer (patients with high intermediary and low risk of developing stress ulcer), indications of SUP and SUP prescription data (drug used and duration of the prophylaxis). Results: The sample was from 208 medical records. The age average was of 65,3 years old and there was a predominance of females (55,8%). Of the total sample, 46,6% of the patients are in the high-risk group of developing stress ulcer , 26,4% in the intermediary risk group and 5,8% are in the low risk group. The SUP was performed in 99% of the patients, being recommended in 26,5%. Ranitidine was the main drug used in SUP with a predominant range of use time between 1 to 5 days. Conclusion: It was proved the high use of SUP in the intensive care unit environment. Became evident that SUP, in the ICU question, happens in a disharmonious way as proposed in the literature, considering that patitens of low risk for development of stress ulcer and without indication for SUP received the drugs.

References

1.Abjaude, SAR. Avaliação do uso profilático de omeprazol em pacientes internados no hospital estadual Américo Brasiliense. 2015

2.Araujo TE, Vieira SM, Carvalho PR. Stress ulcer prophylaxis in pediatric intensive care units. J Pediatr (Rio J). 2010;86(6):525-530

3.Buckley MS, Park AS, Anderson CS, Barletta JF, Bikin DS, Gerkin RD, et al. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients. Am J Med. 2015; 128(8):905-13

4.Buendgens L, Koch A, Tacke F. Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis. World J Crit Care Med. 2016;4;5(1):57-64

5.Chaves NM, Niveia DA. Uso de inhibidores de la bomba de protones y antagonistas de los receptores H2 de histamina como profilaxis en úlceras por estrés:¿ una práctica justificada?. Rev. Colomb. Enferm. 2015; 11(10): 82-92

6.Deerojanawong J, Peongsujarit D, Vivatvakin B, Prapphal N. Incidence and risk factors of upper gastrointestinal bleeding in mechanically ventilated children. Pediatr Crit Care Med. 2009; 10(1):91-5

7.Dellinger PR, Mitchell ML, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Campanha de Sepsis Sobrevivente: diretrizes internacionais para o manejo da sepse grave e choque séptico, 2012. Medicina de cuidados intensivos. 2013; 39(2):165-228

8.Faust AC, Echevarria KL, Attridge RL, Sheperd L, Restrepo MI, Prophylactic Acid-Suppressive Therapy in Hospitalized Adults: Indications, Benefits, and Infectious Complications. Crit Care Nurse. 2017; 37(3):18-29

9.Ikemura M, Nakasako S, Seo R , Atsumi T, Ariyoshi K , Hashida T. Reduction in Gastrointestinal Bleeding by Development and Implementation of a Protocol for Stress Ulcer Prophylaxis: a Before-after Study. Journal of Pharmaceutical Health Care and Sciences. 2015; 1(33)

10.Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008; 135(1):41-60

11.Machado AS, Teixeira C, Furlanetto L, Tonietto T, Balzano PC, Vieira SRR et al. Stress ulcer prophylaxis in intensive care units: an observational multicenter study. Revista Brasileira de terapia intensiva, 2006; 18(3):229-233

12.Marquito AB, Noblat L. Profilaxia para Úlcera de Stress em Unidade de Terapia Intensiva. Arquivos de Medicina. 2011; 25(3):95-99

13.Munari L, Hart D, Morrone FB. Uso de omeprazol em hospital universitário de Porto Alegre-RS (Brasil). Pharmacy Practice, 2004; 2(4):235-243

14.Pomplio CE, Cecconello I. Profilaxia das úlceras associadas ao estresse. ABCD Arq Bras Cir Dig. 2010;23(2):114-117

15.Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care, 2005; 20(1):35-45

Published

2021-12-27